A small study of five people with asthma found that taking a blackcurrant supplement containing anthocyanins for eight weeks reduced daytime and nighttime asthma symptoms and eliminated the need for rescue inhalers during the supplement phase, compared to one person needing a rescue inhaler during the placebo phase. According to Gram Research analysis, these preliminary findings suggest blackcurrant anthocyanins may help control asthma symptoms, but the study was too small to confirm this effect, and larger trials are needed before recommending the supplement as an asthma treatment.

A new study tested whether a supplement made from New Zealand blackcurrants could help people with asthma breathe easier. Researchers gave five people with asthma either a blackcurrant supplement or a fake pill for eight weeks, then switched them. The blackcurrant supplement, which contains powerful plant compounds called anthocyanins, seemed to reduce daytime and nighttime asthma symptoms and people didn’t need their rescue inhalers as often. While these early results are promising, the study was very small, so scientists need to test this in many more people before recommending it as an asthma treatment.

Key Statistics

A 2026 feasibility study of five adults with asthma found that participants taking 300 milligrams of New Zealand blackcurrant anthocyanins for eight weeks required zero rescue inhaler uses, compared to one participant (20 percent) requiring a rescue inhaler during the placebo phase.

According to a 2026 crossover study published in Respiratory Medicine, blackcurrant anthocyanin supplementation resulted in reduced daytime and nighttime asthma symptoms and no activity limitations in all five participants, though the small sample size means findings require confirmation in larger trials.

A 2026 feasibility study found that blackcurrant anthocyanins, compounds with antioxidant and anti-inflammatory properties, showed potential for improving asthma symptom control in a small group of five adults, though researchers emphasized the need for adequately powered studies with larger sample sizes.

The Quick Take

  • What they studied: Whether a supplement made from blackcurrant berries could reduce inflammation and improve asthma symptoms in people with asthma.
  • Who participated: Five adults with asthma participated in this small feasibility study. They tested both the blackcurrant supplement and a placebo (fake pill) over two eight-week periods.
  • Key finding: People taking the blackcurrant supplement reported fewer asthma symptoms during the day and night, and none of them needed to use their rescue inhalers during the supplement phase, compared to one person needing it during the placebo phase.
  • What it means for you: This research suggests blackcurrant supplements might help manage asthma symptoms, but the study was too small to be certain. Anyone with asthma should talk to their doctor before trying supplements, as this finding needs confirmation in larger studies.

The Research Details

This was a crossover feasibility study, which means each participant tried both the blackcurrant supplement and a placebo (fake pill) at different times. The researchers gave five adults with asthma either 300 milligrams of blackcurrant anthocyanins (the active compounds in blackcurrants) or an identical-looking placebo for eight weeks. Then they switched: people who got the real supplement got the fake pill, and vice versa. This design helps researchers see if the supplement works better than a placebo by comparing each person to themselves.

The researchers measured several things to see if the supplement worked. They looked at asthma symptom control by asking people about daytime and nighttime symptoms and activity limitations. They also checked how often people used their rescue inhalers (the quick-relief medications people use during asthma attacks). Additionally, they measured inflammatory markers in breath and saliva to see if the supplement reduced inflammation in the airways.

This study was designed as a feasibility study, meaning its main goal was to test whether a larger study would be possible and to gather information to plan that bigger trial. The researchers wanted to see if people would participate, if they could follow the study protocol, and if there were any early signs that the supplement might work.

Asthma is caused by inflammation and swelling in the airways, making it hard to breathe. Current treatments work well for many people, but researchers are always looking for additional ways to help, especially for people whose asthma doesn’t respond well to standard medications. Blackcurrants contain anthocyanins, which are plant compounds with antioxidant and anti-inflammatory properties. Since oxidative stress (a type of cellular damage) plays a role in asthma, testing whether anthocyanins could help makes scientific sense. This feasibility study provides early evidence that a larger, more rigorous trial is worth conducting.

This study has important limitations that readers should understand. With only five participants, the results are preliminary and may not apply to larger populations. The small sample size means the findings could be due to chance or individual differences rather than the supplement’s true effect. The crossover design is good because it compares each person to themselves, but the study lacked some details about how it was conducted. The researchers acknowledge these limitations and describe this as a feasibility study meant to gather information for planning a larger, more rigorous trial. The findings are exploratory and require confirmation in adequately powered studies with larger sample sizes before any firm conclusions can be drawn.

What the Results Show

During the blackcurrant supplement phase, participants reported improvements in asthma symptom control. Specifically, they experienced reduced daytime symptoms, reduced nighttime symptoms, and no activity limitations due to asthma. Importantly, none of the five participants needed to use their rescue inhalers (short-acting beta-agonists) during the eight-week blackcurrant supplement phase.

In contrast, during the placebo phase, one participant (20 percent of the group) needed to use their rescue inhaler. This difference suggests the supplement may have helped control asthma better than the placebo. However, because the study was so small, this finding could be due to chance or other factors not measured in the study.

The researchers also looked at inflammatory markers in the participants’ breath and saliva to see if the supplement reduced inflammation in the airways. While the abstract doesn’t provide detailed results for these measurements, the study explored whether changes in inflammation markers were related to the supplement’s effects on symptoms.

The researchers explored several other factors that might explain how the blackcurrant supplement works. They looked at a genetic variation called the PAI-1 4G/5G polymorphism, which affects how the body handles a protein involved in airway inflammation. They also examined whether people’s overall diet quality (measured by the Dietary Inflammatory Index) was related to how well the supplement worked. These exploratory analyses were meant to generate ideas for future research rather than provide definitive answers. The study also assessed feasibility outcomes, such as whether participants could follow the study protocol and whether they experienced any side effects, to help plan a larger trial.

This study builds on existing research showing that anthocyanins have antioxidant and anti-inflammatory properties. Previous research has suggested that oxidative stress plays an important role in asthma, which is why testing anthocyanin supplementation in people with asthma makes sense. However, very few studies have specifically tested blackcurrant anthocyanins in people with asthma. This feasibility study is an important first step in determining whether larger, more rigorous trials are warranted. The findings align with the scientific rationale for testing plant-based anti-inflammatory compounds in asthma, but they don’t yet provide strong evidence that the supplement works.

This study has several important limitations. First, it included only five participants, which is extremely small. With such a tiny group, results may not apply to other people with asthma. Second, the study was designed as a feasibility study to test whether a larger trial would be possible, not to prove the supplement works. Third, the study doesn’t provide detailed information about how participants were selected or whether they were similar to the general asthma population. Fourth, the study period was relatively short (eight weeks), so we don’t know if benefits would continue longer or if side effects might develop over time. Fifth, the study doesn’t clearly explain how researchers controlled for other factors that might affect asthma, such as diet, exercise, stress, or environmental triggers. Finally, the small sample size means the findings could easily be due to chance rather than the supplement’s true effect.

The Bottom Line

Based on this very small feasibility study, blackcurrant anthocyanin supplements cannot yet be recommended as an asthma treatment. The findings are preliminary and exploratory. Anyone with asthma should continue taking their prescribed medications as directed by their doctor. If someone is interested in trying blackcurrant supplements, they should discuss this with their healthcare provider first, as supplements can interact with medications and may not be appropriate for everyone. Confidence in these findings is low due to the small sample size and feasibility study design.

People with asthma who are interested in complementary approaches to managing their condition may find this research interesting. Healthcare providers treating asthma patients should be aware of this emerging research. Researchers studying asthma and plant-based anti-inflammatory compounds should pay attention to these preliminary findings. However, this study is too small and preliminary to change current asthma treatment recommendations for any group. People with severe or poorly controlled asthma should not rely on supplements alone and must continue their prescribed medications.

In this small study, participants reported symptom improvements within eight weeks of taking the blackcurrant supplement. However, with such a small sample size, it’s unclear whether these improvements would occur in other people or how long they would last. A larger study would be needed to determine realistic timelines for seeing benefits and whether benefits continue with long-term use.

Frequently Asked Questions

Can blackcurrant supplements help with asthma?

A small 2026 study suggests blackcurrant anthocyanins may reduce asthma symptoms and rescue inhaler use, but the five-person sample is too small to confirm effectiveness. Larger studies are needed before recommending blackcurrant supplements for asthma treatment. Always consult your doctor before trying supplements.

What are anthocyanins and why might they help asthma?

Anthocyanins are plant compounds found in blackcurrants that have antioxidant and anti-inflammatory properties. Since asthma involves airway inflammation and oxidative stress, researchers theorized that anthocyanins might help reduce these problems. This study provides preliminary evidence supporting that theory.

How much blackcurrant supplement did people take in the study?

Participants took 300 milligrams of blackcurrant anthocyanins daily for eight weeks. This is the dose that showed potential benefits in this small feasibility study, though larger trials are needed to confirm the optimal dose and long-term safety.

Is this study proof that blackcurrant supplements treat asthma?

No. This was a small feasibility study with only five participants designed to test whether a larger trial would be possible. The findings are preliminary and exploratory. Much larger, more rigorous studies are needed before blackcurrant supplements can be recommended as an asthma treatment.

Should I stop taking my asthma medications and try blackcurrant supplements instead?

No. Continue taking your prescribed asthma medications exactly as directed by your doctor. Do not replace any medication with supplements. If interested in trying blackcurrant supplements alongside your current treatment, discuss this with your healthcare provider first to ensure safety and avoid interactions.

Want to Apply This Research?

  • Track daily asthma symptoms on a scale of 1 to 10, including daytime symptoms, nighttime symptoms, and activity limitations. Also log rescue inhaler use (number of times per day). Compare symptom scores and inhaler use before and after starting any new supplement, with your doctor’s approval.
  • If your doctor approves, you could test a blackcurrant supplement for eight weeks while tracking your asthma symptoms daily in the app. Record your symptom severity, nighttime awakenings due to asthma, and rescue inhaler use. Compare your baseline symptoms to your symptoms after eight weeks to see if you notice any personal changes.
  • Set up weekly reminders to review your symptom trends. Create a comparison view showing your average symptoms and inhaler use for each month. If you notice improvements, continue tracking to see if benefits persist. If symptoms worsen or don’t improve, discuss this with your doctor. Share your tracked data with your healthcare provider to inform treatment decisions.

This research is preliminary and based on a very small study of five participants. The findings are exploratory and do not yet provide strong evidence that blackcurrant supplements treat asthma. This article is for informational purposes only and should not be considered medical advice. Anyone with asthma should continue taking prescribed medications as directed by their healthcare provider. Before starting any supplement, including blackcurrant anthocyanins, consult with your doctor to discuss potential benefits, risks, and interactions with your current medications. Do not replace prescribed asthma treatments with supplements without medical supervision. If you experience worsening asthma symptoms, seek immediate medical attention.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: The Association Between New Zealand Blackcurrant Anthocyanins and Airway Inflammation, Including PAI-1, in Asthma: A Placebo-Controlled Crossover Feasibility Study. , Respiratory medicine (2026). PubMed 42892393 | DOI
Topics
blackcurrant anthocyanins asthma symptom control natural asthma remedies airway inflammation plant-based anti-inflammatory asthma management rescue inhaler use feasibility study asthma